In this presentation, Parastoo Mashouri, PhD Candidate explores her pioneering research on the effects of gradual ovarian failure on skeletal muscle function.
Utilizing an occupational chemical called VCD, which induces gradual ovarian failure, Parastoo’s work offers a nuanced perspective on the time-course changes in muscle function throughout menopause. She discusses her findings on the contractile properties of skeletal muscles at the single fiber level as well as explores morphological alterations, particularly focusing on fatty infiltration and fibrosis in muscles post-ovarian failure, which will have implications on overall muscle health and function.
This session also highlights the broader implications of these changes, emphasizing the importance of studying the perimenopause phase. Parastoo discusses how understanding the physiological changes during this critical transitional phase can lead to potential strategies for mitigating the negative effects of menopause on women’s health. Attendees will gain insights into the innovative use of the VCD model, contrasting it with the more common ovariectomy model, and learn about the significance of estrogen in maintaining muscle function. This talk aims to provide a comprehensive understanding of the intricate, and rather complex, relationship between menopause and skeletal muscle health, offering new perspectives for future research and potential therapeutic approaches.
Key Topics Include:
- Understand the VCD model: Gain insights into the VCD (4-vinylcyclohexene diepoxide) model of chemically induced ovarian failure and its advantages over the ovariectomy (OVX) model.
- Explore skeletal muscle changes: Learn about the impact of gradual ovarian failure on the contractile properties and morphology of skeletal muscles.
- Time course changes of menopause: Understand the importance of studying menopause as a dynamic process rather than a singular timepoint, and how this perspective can lead to more accurate interpretations of research findings.
- Evaluate broader implications: Consider the broader implications of menopause-related muscle changes on women’s health and potential future direction suggestions for the field to help identify strategies for mitigating negative effects.
Click to watch the webinar recording. To view the presentation full screen simply click the square icon located in the bottom-right corner of the video-viewer.
Presenters
PhD Candidate
Human Health and Nutritional Sciences
University of Guelph
Parastoo Mashouri's doctoral research focuses on understanding the effects of perimenopause and menopause on skeletal muscle function. In particular, her work explores menopause’s effects on the contractile properties of skeletal muscles at the single fiber level as well as morphological changes in muscle such as fat infiltration and fibrosis.
Production Partner
Aurora Scientific, Inc.
Aurora Scientific supports the scientific community in its goal of research and discovery by providing precision instrumentation of the highest quality design, construction and functionality for Muscle Physiology, Material Science and Neuroscience applications.
Additional Content From Aurora Scientific, Inc.
Skeletal Muscle Circadian Clocks: Keeping Time for Systemic Health
Dr. Karyn Esser presents the critical role of skeletal muscle circadian clocks in maintaining muscle strength, metabolic health, and systemic adaptations to endurance exercise.
Redox Regulation of Skeletal Muscle: A Journey from Liverpool to the International Space Station
Dr. Anne McArdle and Dr. Malcolm Jackson explore groundbreaking research from the Muscle Laboratories at the University of Liverpool. They examine how redox regulation influences the adaptive responses of skeletal muscle during physical activity and how these processes evolve with age.
Molecular Signals Mediating Increases in Muscle Size and Function
In this webinar, Dr. Bert Blaauw elucidates skeletal muscle regulatory pathways and offers approaches to tackle muscle deficits for therapy.
Additional Content From American Physiological Society
Engineering Neuromodulation for Cardiovascular Instability
Dr. Aaron Phillips traces the translational journey of a discovery that began in a foundational laboratory and is now advancing through pivotal clinical trials aimed at stabilizing cardiovascular function.
Animal Welfare in Surgery: Then and Now
In this presentation, Dr. René Remie transports you back five decades to explore the foundational principles of surgery that have evolved into what we now recognize as Good Surgical Practice (GSP).
The Trainer’s Toolkit for Osmotic Pumps: Supporting Researchers in Infusion Studies
Explore how osmotic pumps can revolutionize in vivo research by enhancing drug delivery effectiveness. Learn about the preparation, implantation, and integration of these devices into research protocols, and gain practical insights for training investigators and lab personnel.
Additional Content From Society for Women’s Health Research
Hypertension and Hypothalamic Changes in a Mouse Model of Menopause
Dr. Teresa Milner presents research using a mouse model of accelerated ovarian failure to explore estrogen's role in menopausal hypertension, highlighting the therapeutic potential of estrogen receptor beta agonists during menopause transition.
New Treatments for Vasomotor Symptoms Due to Menopause
Dr. JoAnn Pinkerton delves into the vasomotor symptoms associated with menopause, the current understanding of the physiological mechanisms involved, and the pharmacotherapies and treatments available.
Challenges and Opportunities for Treatment of Metastatic Breast Cancer
Join Dr. Marsha Rosner as she explores innovative strategies and novel approaches to tackle the challenges of metastatic triple-negative breast cancer, a particularly aggressive form of cancer affecting a diverse group of women.
Additional Content From Scientist.com
How to Avoid Expensive Redesign Cycles in Antibody Discovery
Learn how integrated antibody discovery and engineering strategies can accelerate the path from hit to optimized lead in less than 12 months while minimizing costly redesign cycles.
Beyond Exposure: Integrating PK/PD for Translational Predictive Power
Learn to integrate PK/PD modeling and strategic biomarkers to bridge the translational gap. Improve clinical predictability for NCEs, ADCs, and large molecules in this technical webinar.
Advancing the Manufacture of Mesenchymal Stromal Cells and Derived Extracellular Vesicles in Stirred-Tank Bioreactors Through Enhanced Bioprocess Control
Learn how to scale the production of MSCs and extracellular vesicles using bioreactor control and real-time monitoring for more consistent therapies.
Related Content
Control of Muscle Glucose Uptake in vivo: Thinking Outside the Myocyte
In this webinar, David Wasserman, PhD provides a more complete understanding of muscle glucose uptake through consideration of the integration of physiological systems that control this process.
Cut and Paste of Myosin Binding Protein-C in Striated Muscles
Dr. Samantha Harris discusses the development of three new mouse models in her lab, engineered to target and replace specific myosin binding protein-C paralogs in muscle fibers and impact of their mutations on skeletal and cardiac muscle diseases.
Integrating Patient Engagement and Trainee Development in Pre-Clinical Research
Christopher Perry, PhD discusses how his laboratory aims to discover mechanisms by which metabolic dysfunction causes muscle weakness and apply these findings to develop new therapies for muscle disorders. Homira Osman, PhD provides a particular focus on leveraging scientific findings for practice and policy and linking trainees with patient communities.